Dr. Johnson’s appointment to The National Academies Forum on Drug Discovery, Development, and Translation will run through Dec. 31, 2027. The forum is part of the Health and Medicine Division of the National Academies of Sciences, Engineering and Medicine.
This forum will hold public workshops, action collaboratives and meetings that are neutral venues where varying experiences can be shared and built upon. Members of the forum will also work together to spur cross-sector collaboration to develop practical approaches for advancing a clinical trials enterprise that is more efficient, effective and patient-centered and also integrated into the health delivery system.
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.